DUBAI, U.A.E, Sept. 15, 2020 /PRNewswire/ -- The global fungal testing kits market is anticipated to grow strikingly at a CAGR of 10.2% amid the assessment period, 2020-2030.
Growing prevalence of systemic and superficial fungal infections, on-going schemes to promote and develop antifungal drugs testing, broader commercial accessibility of enhanced diagnostics, increasing awareness programs, heightening life expectancy and growth of real-time testing methods are projected to complement growth of the global market in the approaching years. Companies are focusing on making the kits affordable and cost-effective is at the keystone of vendors, since majority of the populace in growing economies have low disposable incomes. Thus, attempts are ongoing to offer affordable testing kits.
Governments are speeding up efforts to get over barriers such as conservative social and cultural perceptions in certain regions concerning certain diseases such as fungal infections.
With huge uncertainty looming over individual's heads due to COVID-19 pandemic, a huge economic slump is on the cards. Despite this, the healthcare sector stay stoic, dedicated to eliminate the pandemic as soon as possible.
"Incessant focus on integrating technological progressions to enhance diagnostic outcomes stays the central objective of the companies, allowing them to expand their revenue pools," opines FMI analyst.
For more insights into the Market, Request a Sample of this [email protected] https://www.futuremarketinsights.com/reports/sample/rep-gb-12418
Fungal Testing Kits Market - Major Takeaways
- Medical diagnosis to stay fundamental application area, producing an attractiveness index of 2.8.
- Skin samples are projected to gain the prominent share, holding more than 40% of the market due to a rising prevalance of superficial fungal infections such as yeast, athlete's foot and ringworm infections.
- Molecular detection tests to loom over others, accounting for US$ 1.6 Bn through 2030.
- Broadening expenditure on healthcare infrastructure to elevate demand all over Asia-Pacific.
Fungal Testing Kits Market - Key Drivers
- Growing geriatric population and vulnerability to the fungal infections has witnessed immense proliferation, which, in turn recorded an impressive upsurge in the market in the long term.
- Increasing instances of several fungal infections and the commercial availability of diagnostic tests is burgeoning, this is projected to raise the market to higher echelons over the years to come.
Fungal Testing Kits Market - Regional Analysis
- North America will remain as the dominant market, due to high occurrence and diagnostics of infectious ailments.
- The European market for fungal testing kits is projected to account for significant sway, gaining close to 30% of the global revenue share during the assessment period.
Fungal Testing Kits Market - Competitive Landscape
Major companies identified in the global market for fungal testing kits include Thermo Fisher Scientific, Merck KGaA, bioMerieux SA, PerkinElmer Inc., ELITech Group, GenMark Diagnostics Incorporation, C.P.M. Diagnostic Research, Norgen Biotek, Biomed Diagnostics Incorporation, F.Hoffman LaRoche Limited., PCRmax, Bioquochem and Hologic Inc. Companies are focusing on partnerships, collaborations and acquisitions to develop lucrative diagnostic kits. For instance,
GenMark Diagnostics Inc. reported details concerning the effectivity of a PCR-based electrochemical detection and digital microfluidics system for fast recognition of 15 fungous pathogens. The system intends at finding pathogenic activity direct from positive blood cultures.
For any Queries Linked with the Report, Ask an [email protected] https://www.futuremarketinsights.com/ask-question/rep-gb-12418
Fungal Testing Kits Market - Taxonomy
- Molecular Test
- Chromogenic Test
- Vaginal Secretions
- Susceptibility Testing
- Medical Diagnosis
- Diagnostic Laboratory
- Pharmaceutical Companies
- Research and Academic Institutes
- North America
- Latin America
- South Asia
- East Asia
- Middle East & Africa
Get Valuable Insights into the Fungal Testing Kits Market
Future Market Insights, in its new offering, provides an unbiased analysis of the global fungal testing kits market, presenting historical demand data and forecast statistics for the period from 2020-2030. The study divulges compelling insights on the fungal testing kits market, allowing readers to glean qualitative and quantitative information which will enable them to make informed market decisions in the upcoming forecast period.
Explore Extensive Coverage on FMI's Testing Landscape
Cancer Tissue Diagnostics Market: The cancer tissue diagnostics market is anticipated to surpass an impressive revenue threshold by the end of the forecast period ranging from 2016 to 2026, concludes FMI's recently published research report on the market.
Allergy Diagnostics Market: FMI's compelling study on the allergy diagnostics market sheds light on the prominent dynamics influencing the growth trajectory for the upcoming forecast period 2017-2022 through detailed segmental and regional analyses.
Hematology Diagnostics Market: The hematology diagnostics market report offers a 360-degree analysis, bringing to the fore insights that can help stakeholders identify key challenges and opportunities across the upcoming decade's growth trajectory.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: [email protected]
For Media Enquiries: [email protected]
SOURCE Future Market Insights